2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 4 filers reported holding 2SEVENTY BIO INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $174 | +278.3% | 44,436 | +879.2% | 0.01% | +250.0% |
Q2 2023 | $46 | -2.1% | 4,538 | -0.5% | 0.00% | 0.0% |
Q1 2023 | $47 | +9.3% | 4,562 | -0.4% | 0.00% | 0.0% |
Q4 2022 | $43 | -99.9% | 4,579 | -10.9% | 0.00% | -33.3% |
Q3 2022 | $75,000 | -2.6% | 5,140 | -11.5% | 0.00% | +50.0% |
Q2 2022 | $77,000 | -21.4% | 5,807 | +1.5% | 0.00% | 0.0% |
Q1 2022 | $98,000 | -41.7% | 5,724 | -12.8% | 0.00% | -33.3% |
Q4 2021 | $168,000 | – | 6,566 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 819,672 | $10,820,000 | 4.13% |
Madison Avenue Partners, LP | 1,511,300 | $19,949,000 | 4.08% |
Newtyn Management, LLC | 1,346,796 | $17,778,000 | 3.37% |
Bain Capital Life Sciences Investors, LLC | 1,408,901 | $18,597,000 | 2.18% |
EcoR1 Capital, LLC | 3,495,943 | $46,146,000 | 1.59% |
Casdin Capital, LLC | 614,754 | $8,115,000 | 0.69% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $3,960,000 | 0.60% |
Birchview Capital, LP | 59,833 | $790,000 | 0.58% |
CAAS CAPITAL MANAGEMENT LP | 699,136 | $9,229,000 | 0.46% |
Altium Capital Management LP | 83,000 | $1,096,000 | 0.44% |